Trial
NCT02382588
Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Bausch & Lomb Incorporated
Condition
Herpes Zoster Keratitis
Intervention
gancyclovir gel
Why stopped
There were difficulties meeting the enrollment goal within stipulated time frames.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-08